Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IGF-I | 100 | ug/mL | 3 | LIF | 158.0 | 49 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 177.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 114.0 | 57 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 497.5 | 74 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 113.0 | 74 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 108.0 | 54 | |
N2586 | 3 | LIF | 184.5 | 50 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | LIF | 86.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | LIF | 87.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 121.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 148.5 | 44 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 103.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | LIF | 73.0 | 50 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | LIF | 127.0 | 55 | ||||
N2586 | EGF | 100 | ng/mL | 3 | LIF | 173.0 | 47 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | LIF | 168.5 | 50 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 175.0 | 67 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 296.5 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | LIF | 128.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | LIF | 126.0 | 72 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | LIF | 77.5 | 64 | ||||
RA2159 | 3 | LIF | 97.5 | 50 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | LIF | 81.0 | 50 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | LIF | 68.0 | 73 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | LIF | 92.5 | 50 |